What Providers Need to Know about Lecanemab
Dr. Jason Karlawish, co-director of the Penn Memory Center, discusses the groundbreaking use of lecanemab in treating Alzheimer's disease at Penn Medicine. He explains the importance of early diagnosis, patient eligibility, and the promising future of dementia care. Learn about this revolutionary approach to slowing down Alzheimer's progression and how it's changing the landscape of cognitive impairment treatment.
#PennMedicine
